Stefan Oelrich has been newly elected President of the EFPIA, as new leadership calls for action to restore Europe’s global leadership in pharma innovation.

The body is eliminating of Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed CAR T-cell therapies.

Ascroft brings more than 30 years of industry experience, including senior roles at Takeda Pharmaceuticals.

The US plans to stop its financial contributions to Gavi, the Vaccine Alliance, marking an end to an over 20-year partnership.

The survey found that, while 57% of patients support the use of AI in the examination room, they are less enthusiastic about diagnostics.

The FDA has launched an immediate review of clinical trials involving the export of American patients’ living cells to China and other “hostile countries”.

A UK project has received a £1.8m to transform how medicines are made, aiming to make drug manufacturing faster, cleaner and more responsive.

The UK government has set out a 10 Year Health Plan, promising to transform clinical trials and make the UK a scientific superpower.